There are other genomics based biomarkers that have been proposed to predict poor prognosis in PCa namely, PSCA, EZH2, TMPRSS2-ERG, E-cadherin, N-cadherin, ZEB1, and RASSF1A [47–52]. This evidence concerns the gene RASSF1 and posterior cortical atrophy.